Differences in body mass index among individuals with PsA, psoriasis, RA and the general population

dc.contributor.authorBhole, Vidula M.
dc.contributor.authorChoi, Hyon K.
dc.contributor.authorBurns, Lindsay C.
dc.contributor.authorVera Kellet, Cristián Andrés
dc.contributor.authorLacaille, Diane V.
dc.contributor.authorGladman, Dafna D.
dc.contributor.authorDutz, Jan P.
dc.date.accessioned2024-01-10T12:38:22Z
dc.date.available2024-01-10T12:38:22Z
dc.date.issued2012
dc.description.abstractObjectives. To compare obesity among individuals with PsA, psoriasis (PsO), RA and the general population (n), and identify correlates of obesity among individuals with PsO and PsA.
dc.description.abstractMethods. We compared the BMI of patients with PsA (n = 644), PsO (n = 448), RA (n = 350) and the general population using age- and sex-adjusted linear and logistic regression analyses. We conducted multivariate analyses limited to PsO and PsA to determine correlates of BMI and obesity.
dc.description.abstractResults. The mean BMI (kilogram per square metre) for individuals with PsA, PsO, RA and the general population were 29.6, 27.9, 27.3 and 26.1, respectively. The proportion with obesity was 37, 29, 27 and 18% for individuals with PsA, PsO, RA and the general population, respectively. The differences in BMI were significant between all categories (P < 0.05) except between PsO and RA. Age- and sex-adjusted linear and logistic regression confirmed that these differences were significant. In multivariate logistic regression analyses adjusted for age, sex, smoking, PsO duration, psoriasis area severity index score, use of DMARDs, glucocorticoids and biologics, the odds of obesity were 61% higher for PsA patients than PsO patients (95% CI 1.10, 2.37). When we additionally adjusted for the physical component summary of the short form-36, the association was attenuated and became insignificant.
dc.description.abstractConclusions. Individuals with PsA have a higher mean BMI than those with PsO, RA or the general population. The BMI difference between PsA and PsO correlates with physical health.
dc.description.funderChild and Family Research Institute
dc.description.funderCIHR New Emerging Team
dc.fechaingreso.objetodigital2024-04-29
dc.format.extent5 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1093/rheumatology/ker349
dc.identifier.issn1462-0324
dc.identifier.pubmedidMEDLINE:22120603
dc.identifier.urihttps://doi.org/10.1093/rheumatology/ker349
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/77032
dc.identifier.wosidWOS:000300789000021
dc.information.autorucMedicina;Vera C;S/I;9379
dc.issue.numero3
dc.language.isoen
dc.nota.accesocontenido parcial
dc.pagina.final556
dc.pagina.inicio552
dc.publisherOXFORD UNIV PRESS
dc.revistaRHEUMATOLOGY
dc.rightsacceso restringido
dc.subjectpsoriasis
dc.subjectpsoriatic arthritis
dc.subjectrheumatoid arthritis
dc.subjectbody mass index
dc.subjectobesity
dc.subjectRHEUMATOID-ARTHRITIS
dc.subjectUNITED-STATES
dc.subjectRISK-FACTORS
dc.subjectOBESITY
dc.subjectSMOKING
dc.subjectDISEASE
dc.subjectINFLAMMATION
dc.subjectCARE
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleDifferences in body mass index among individuals with PsA, psoriasis, RA and the general population
dc.typeartículo
dc.volumen51
sipa.codpersvinculados9379
sipa.indexWOS
sipa.indexScopus
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population.pdf
Size:
2.98 KB
Format:
Adobe Portable Document Format
Description: